CNA: The Covid-19 vaccine developed at the University of Oxford which Beximco Pharmaceuticals Ltd will “exclusivly distribute” in Bangladesh, appears perfect and builds strong immunity to the virus.
 Earlier, Beximco Pharmaceuticals Ltd also known as Beximco Pharma has announced that it would invest with Serum Institute of India (SII) for the development of the Oxford/AstraZeneca vaccine (AZD1222).Scottish First Minister Nicola Sturgeon announced on Friday a five-level system of coronavirus restrictions.
 England currently has a three-tier system, and Wales and Northern Ireland have both opted for short, national “circuit-breaker” lockdowns. “We don’t have to take a one-size-fits-all approach if that is not warranted,” Sturgeon said at a news conference.“We do not envisage returning to a situation as severe as the first lockdown,” she said.
Sturgeon will put her proposal to a vote in the Scottish parliament next week.Once approved, the Scottish government will decide which regions will go into which levels, with the restrictions.
coming into force on Nov. 2.
Level 0 will be “the closest to normality we can safely get to without more effective treatments for COVID or a vaccine against COVID,” she said.
In this level, coronavirus is “very suppressed but still a threat.” Eight people from three different households can meet indoors, and businesses will largely be allowed to open so long as COVID-19 safety measures are in place.